|
Richmond, TX (March 1, 2007) - CYNACON/OCuSOFT®,
a broad based supplier of ophthalmic pharmaceuticals and supplies,
is pleased to announce the reclassification of Tears Again® HYDRATE™ to a prescription-only oral supplement to treat
Dry Eye Syndrome.
Tears Again® HYDRATE™ is a Medical Food specially
formulated for the Dietary Management of Dry Eye Syndrome,
Blepharitis, and Meibomian Gland Dysfunction. Tears Again® HYDRATE™ is
intended to be used under the supervision of a physician. Tears
Again® HYDRATE™ is formulated to contain the omega-3
fatty acid, Flaxseed Oil, but has also included Evening Primrose
Oil (EPO), a substance having exceptionally high content of
the even rarer essential fatty acid, gamma linolenic acid (omega-6).
These essential fatty acids (EFA) have been combined with Bilberry
Extract (BBE), all of which provide anti-inflammatory properties – a
component in Dry Eye Syndrome.
The clinically-supported ingredients
in Tears Again® HYDRATE™ aid
in the treatment of inflammatory conditions of the eye. Recent
reports suggest that omega-3 and omega-6 supplementation provide
anti-inflammatory properties-a component in Dry Eye Syndrome.
Tears Again® HYDRATE™ utilizes Hypersorb®, a proprietary
liposome process that has been proven to enhance the absorption
of these ingredients for better bioavailability. This delivery
system is especially suited for oral delivery of drugs with
poor bioavailability such as newly discovered drugs, proteins
and peptides that are not soluble with conventional technologies.
Patrick
Witham, Executive Vice President remarks, “Hypersorb® is
one of the most significant developments in oral pharmaceutics
within the last decade. Essential fatty acids are “essential” due
to the fact that the body does not produce EFAs, so they must
be supplemented through diet. Unfortunately, some patients simply
cannot tolerate these oils (particularly fish oils) in the digestive
system. With Hypersorb®, the new liposome process, absorption
should improve, leading to better bioavailability and increased
tolerability.”
Cynthia Barratt, President, notes, "We have made the decision
to take this step in classifying Tears Again® HYDRATE as
a prescription-only product with a complete understanding of
the complexity of inflammatory conditions of the eye such as:
Dry Eye Syndrome, Blepharitis and Meibomian Gland Dysfunction.
For too long supplements have been used indiscriminately without
regard to the risks associated. While supplements are generally
safe, they are not without some risk. For example, blood platelet
aggregation can be affected by the ingestion of flaxseed oil.
Simple dry eyes may progress to a more serious corneal disorder.
Accordingly, we feel such patients are better managed and cared
for under the supervision of a physician.”
More information on Tears Again® HYDRATE™ can
be found at www.tearsagainhydrate.com.
For more information about this and other CYNACON/OCuSOFT® products,
please contact:
Troy Smith, Vice President of Sales
Phone: 800.233.5469; 281.342.3350
Email: tsmith@ocusoft.com |
|
